ATG12 and Parkinson disease: In the only conducted study in this field, Li et al. found five novel heterozygous polymorphisms in sporadic PD patients which can alter the transcriptional activity of ATG12. However, the ATG12 rs26538 C > T did not represent any statistically significant difference between healthy and PD groups [21].